what is always revealing are those who try *normalize* the abnormal
as if the easiest aspect NR (non retail) controls isn't the targeted company's PPS

it is

and after 4 years of unrelenting PPS *compression* .. NR has the ability to impact a company's ability to execute

then factor in that everything in the real world takes far longer than most (seemingly) on SMBs acknowledge or expect

and it becomes an interesting and beyond revealing dance that gets done

everyone here knows full well what mgmt's response was to NRs' set up (2015)

an upside down (significantly so) NR only wants one thing .. investors to sell
and the company to shutter its doors

and because Innovation Pharma has a variety of options .. their survival and ability to outlast NR .. will cost NR .. the *cost* will depend on what option is chosen by mgmt

and that is why this *dance* is so interesting to some .. imo

4kids